ROLE OF POINT MUTATION OF THE K-RAS GENE IN TUMORIGENESIS OF B6C3F(1) MOUSE LUNG LESIONS INDUCED BY URETHANE

被引:34
作者
KAWANO, R
NISHISAKA, T
TAKESHIMA, Y
YONEHARA, S
INAI, K
机构
[1] Second Department of Pathology, Hiroshima University School of Medicine, Hiroshima, 734, Kasumi 1-2-3, Minami-ku
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1995年 / 86卷 / 09期
关键词
URETHANE; ETHYL CARBAMATE; K-RAS GENE; B6C3F(1) MOUSE; LUNG TUMOR;
D O I
10.1111/j.1349-7006.1995.tb03089.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to elucidate the role of point mutation of the K-rns gene in the tumorigenetic process of lung tumors, an experimental model of lung lesions in mice induced by the administration of methane was used. A total of 135 B6C3F(1) male mice, 6 weeks old, were given methane in the drinking water at 0, 6, 60, 600 or 1200 ppm, and were then killed after varying periods of time. The lung lesions were histologically characterized as hyperplasia, adenoma and adenocarcinoma. Point mutations in codons 12 and 61 of the R-ras gene were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and confirmed by using dideoxy sequencing analysis. K-ras gene mutation was identified in 9 (23.7%) of 38 lesions classified as hyperplasia, 31 (46.3%) of 67 adenomas, and 3 (50%) of 6 adenocarcinomas. The most frequent mutation was an AT-to-TA transversion at the second base of codon 61 and this pattern accounted for 65% of the three mutant forms observed. These results suggest that the point mutation of R-ras gene is involved in all stages of mouse lung tumorigenesis, i.e., activation of this gene can also influence the later stages of lung lesions.
引用
收藏
页码:802 / 810
页数:9
相关论文
共 37 条
[1]  
ALLEN JW, 1986, CANCER RES, V46, P4911
[2]   ACTIVATION OF THE MOUSE CELLULAR HARVEY-RAS GENE IN CHEMICALLY-INDUCED BENIGN SKIN PAPILLOMAS [J].
BALMAIN, A ;
RAMSDEN, M ;
BOWDEN, GT ;
SMITH, J .
NATURE, 1984, 307 (5952) :658-660
[3]  
BELINSKY SA, 1992, CANCER RES, V52, P3164
[4]  
BELINSKY SA, 1990, CANCER RES, V50, P3772
[5]  
BELINSKY SA, 1989, CANCER RES, V49, P5305
[6]  
BOS JL, 1989, CANCER RES, V49, P4682
[7]  
CANDRIAN U, 1991, CANCER RES, V51, P1148
[8]  
CERNY WL, 1992, CANCER RES, V52, P4507
[9]  
COROMINAS M, 1991, ONCOGENE, V6, P645
[10]  
DAHL GA, 1980, CANCER RES, V40, P1194